It seems that well being care spending as a share of GDP has leveled off. Whereas reaching shut to twenty% of GDP throughout the pandemic, 2022 had well being care spending (17.3% of GDP) extra according to pre-pandemic norms. Hartman et al. (2023) studies:
Well being care spending within the US grew 4.1 p.c to succeed in $4.5 trillion in 2022, which was nonetheless a sooner fee of progress than the rise of three.2 p.c in 2021 however was a lot slower than the speed of 10.6 p.c seen in 2020. In 2022, sturdy Medicaid and personal medical health insurance spending progress, together with a turnaround within the web value of insurance coverage, was considerably offset by continued declines in federal spending related to the COVID-19 pandemic. The insured share of the inhabitants reached a historic excessive of 92.0 p.c in 2022 as enrollment in non-public medical health insurance elevated at a sooner fee relative to 2021 and Medicaid enrollment continued to expertise sturdy progress. The share of the economic system accounted for by the well being sector was 17.3 p.c in 2022, which was down from a peak of 19.5 p.c in 2020 however was extra in keeping with the common share of 17.5 p.c throughout 2016–19.
Pharmaceutical spending as a share of whole well being care spending has been comparatively fixed at round 9% all through the previous 7 years.
You’ll be able to learn extra attention-grabbing statistics within the full article right here.
